EP12.01. Prognostic Value of Sequential Liquid Biopsy (LB) after Osimertinib Among Hispanic Patients with Advanced EGFR-Mutant NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Andres Cardona
Meta Tag
Speaker Andres Cardona
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
liquid biopsy
Osimertinib treatment
Hispanic patients
EGFR-mutant non-small cell lung cancer
prognostic value
molecular profiling
cfDNA positivity
progression-free survival
overall survival
adaptive therapy
Powered By